Case number 2023-1952
Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 20, 2024 | 13 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [1012021] [22-2153, 23-1952] [MVH] [Entered: 06/20/2024 09:38 AM] (1) |
| Apr 11, 2024 | 11 | OPINION filed for the court by Lourie, Circuit Judge; Chen, Circuit Judge and Cunningham, Circuit Judge. Cunningham, Circuit Judge, dissenting in part. Precedential Opinion. Service as of this date by the Clerk of Court. [996710] [22-2153, 23-1952] [MVH] [Entered: 04/11/2024 10:51 AM] (29) |
| Apr 11, 2024 | 12 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [996711] [22-2153, 23-1952] [MVH] [Entered: 04/11/2024 10:52 AM] (1) |
| Jun 13, 2023 | 6 | Entry of Appearance for William R. Peterson; Michael J. Abernathy; Julie S. Goldemberg; Michael T. Sikora; Karon N. Fowler as counsel for Appellees Bausch Health Ireland Ltd., Alfasigma S.p.A., Salix Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd.. Service: 06/13/2023 by email. [929495] [23-1952] [William Peterson] [Entered: 06/13/2023 09:45 AM] (2) |
| Jun 13, 2023 | 7 | Docketing Statement for the Appellees Alfasigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd.. Service: 06/13/2023 by email. [929497] [23-1952] [William Peterson] [Entered: 06/13/2023 09:47 AM] (2) |
| Jun 13, 2023 | 8 | Certificate of Interest for Appellees Alfasigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd.. Service: 06/13/2023 by email. [929502] [23-1952] [William Peterson] [Entered: 06/13/2023 09:49 AM] (4) |
| Jun 13, 2023 | 9 | Notice of Related Case Information for Appellees Alfasigma S.p.A., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd.. Service: 06/13/2023 by email. [929504] [23-1952] [William Peterson] [Entered: 06/13/2023 09:50 AM] (2) |
| Jun 13, 2023 | 10 | Note to File: The following cases are consolidated: 22-2153 Lead with 23-1952 Cross-Appeal. The parties must file all documents in the lead appeal only. [929730] [22-2153, 23-1952] [KMH] [Entered: 06/13/2023 02:39 PM] (0) |
| Jun 7, 2023 | 2 | Entry of Appearance for Chad Landmon; Matthew Murphy; Thomas Hedemann; Matthew Becker as counsel for Appellant Norwich Pharmaceuticals Inc.. Service: 06/07/2023 by email. [928503] [23-1952] [Matthew Murphy] [Entered: 06/07/2023 03:52 PM] (4) |
| Jun 7, 2023 | 3 | Certificate of Interest for Appellant Norwich Pharmaceuticals Inc.. Service: 06/07/2023 by email. [928505] [23-1952] [Matthew Murphy] [Entered: 06/07/2023 03:53 PM] (5) |
| Jun 7, 2023 | 4 | Docketing Statement for the Appellant Norwich Pharmaceuticals Inc.. Service: 06/07/2023 by email. [928506] [23-1952] [Matthew Murphy] [Entered: 06/07/2023 03:54 PM] (4) |
| Jun 7, 2023 | 5 | Notice of Related Case Information for Appellant Norwich Pharmaceuticals Inc.. Service: 06/07/2023 by email. [928507] [23-1952] [Matthew Murphy] [Entered: 06/07/2023 03:55 PM] (4) |
| May 30, 2023 | 1 | Appeal docketed. Received: 05/22/2023. [926423]Entry of Appearance due 06/13/2023. Certificate of Interest is due on 06/13/2023. Docketing Statement due 06/13/2023. Appellant/Petitioner's brief is due 07/31/2023. [KMH] [Entered: 05/30/2023 10:53 AM] (37) |
